Prader-Willi syndrome: guidance for children and transition into adulthood

Area of Science:

• Genetics
• Neurodevelopmental Disorders
• Pediatrics

Background:

• Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder affecting approximately 1 in 10,000-30,000 births.
• Key features include neonatal hypotonia, feeding issues, followed by hyperphagia and obesity risk.
• Associated conditions include developmental delay, learning disability, endocrinopathies, scoliosis, respiratory issues, behavioral challenges, and mental health concerns.

Purpose of the Study:

• To provide a consensus statement and reference document for clinicians managing children and adolescents (up to 18 years) with PWS.
• To outline best practices for diagnosis, clinical assessment, and management across bio-psycho-social domains.
• To guide the transition of care from pediatric to adult services.

Main Methods:

• Development of guidance based on peer-reviewed scientific reports.
• Incorporation of expertise from experienced clinicians in the UK and Ireland.
• Consideration of the full spectrum of PWS management in the pediatric setting.

Main Results:

• The consensus statement addresses the multi-disciplinary approach required for PWS management.
• It covers diagnosis, clinical assessment, and management strategies for children and adolescents.
• Guidance extends to the transition period and ongoing care into adulthood.

Conclusions:

• Effective management of PWS necessitates a comprehensive, multi-disciplinary approach.
• This consensus statement offers essential guidance for healthcare professionals caring for pediatric PWS patients.
• The document supports optimal patient outcomes through informed clinical practice and care transition.